Consequences Of Fetal Growth Restriction Due To Maternal High-Risk Factors On Neonatal Outcome With 1 Year Follow Up In A Tertiary Care Hospital
DOI:
https://doi.org/10.51168/sjhrafrica.v6i6.1758Keywords:
Fetal growth restriction, maternal risk factors, neonatal outcomes, developmental delayAbstract
Background: Fetal growth restriction (FGR) is a significant perinatal concern associated with increased neonatal morbidity and long-term pediatric complications. Maternal high-risk factors such as hypertension, diabetes, malnutrition, and infections are known contributors to FGR.
Objectives:
- To evaluate the consequences of FGR in neonates born to mothers with high-risk conditions in a tertiary care setting.
- To evaluate the pediatric outcome after 1 year follow up.
Methods: A prospective observational study was conducted at IGIMS, Patna, over 1.5 years involving 92 FGR neonates. Maternal risk factors and neonatal outcomes were recorded, with follow-up assessments up to 12 months to evaluate growth and development.
Results: Hypertensive disorders (52.2%) and diabetes mellitus (19.6%) were the most common maternal risk factors. Common neonatal complications included hypoglycemia (37.0%), respiratory distress (31.5%), and NICU admissions (55.4%). At 12 months, 29.3% had delayed milestones, and 33.7% showed persistent growth impairment. Significant correlations were found between maternal conditions and adverse pediatric outcomes.
Conclusion: Maternal high-risk conditions significantly affect both immediate and long-term outcomes in FGR neonates. Early antenatal intervention and structured pediatric follow-up are essential to improve prognosis.
References
Baschat AA. Fetal growth restriction–from observation to intervention. J Perinat Med. 2010;38(3):239–246. doi:10.1515/jpm.2010.035
Figueras F, Gratacós E. Update on the diagnosis and classification of fetal growth restriction and proposal of a stage-based management protocol. Fetal Diagn Ther. 2014;36(2):86–98. doi:10.1159/000357592
Lees CC, Stampalija T, Baschat A. Clinical update: Fetal growth restriction. Lancet. 2022;400(10360):1737–1748. doi:10.1016/S0140-6736(22)01736-6
Melamed N, Baschat A, Yinon Y, et al. FIGO (International Federation of Gynecology and Obstetrics) initiative on fetal growth: best practice advice for screening, diagnosis, and management of fetal growth restriction. Int J Gynaecol Obstet. 2021;152 Suppl 1:3–57. doi:10.1002/ijgo.13575
Bernstein IM, Horbar JD, Badger GJ, Ohlsson A, Golan A. Morbidity and mortality among very-low-birth-weight neonates with intrauterine growth restriction. Am J Obstet Gynecol. 2000;182(1 Pt 1):198–206. doi:10.1016/S0002-9378(00)70513-8
Sharma D, Shastri S, Sharma P. Intrauterine growth restriction: antenatal and postnatal aspects. Clin Med Insights Pediatr. 2016;10:67 83. doi:10.4137/CMPed.S40070
Reddy UM, Abuhamad AZ, Levine D, Saade GR. Fetal growth restriction: evaluation and management. Am J Obstet Gynecol. 2019;221(2):B2–B15. doi:10.1016/j.ajog.2019.05.042
Bhatia A, Dutta S, Narang A. Longitudinal growth and neurodevelopmental outcome of very low birth weight infants at 18 to 24 months of corrected age. Indian Pediatr. 2021;58(2):123–128.
Villar J, Papageorghiou AT, Pang R, et al. The likeness of fetal growth and newborn size across non-isolated populations in the INTERGROWTH-21st Project. BJOG. 2014;121 Suppl 1:28–40. doi:10.1111/1471-0528.12631
Lee ACC, Kozuki N, Blencowe H, et al. Intrauterine growth restriction–associated neonatal mortality: An individual-level meta-analysis. PLoS Med. 2017;14(1):e1002244. doi:10.1371/journal.pmed.1002244
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Rizwan Ahmar, Manish Kumar, Amit Kumar, Sadia Parween, Sunil Kishore, Anand Kumar Gupta

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.